Skip to main content

Target Discovery and Validation in Pancreatic Cancer

  • Protocol
Target Discovery and Validation Reviews and Protocols

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 360))

Summary

Pancreatic cancer is a lethal disease and rational strategies fo gene expression, and mass spectrometric analysis of proteins, have led to identification of cellular targets with considerable potential for clinical application and patient care. These studies underscore the importance of pursuing large-scale profiling of human cancers not only for furthering our understanding of the pathogenesis of these malignancies but also for developing strategies to improve patient outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yeo, T. P., Hruban. R. H., Leach, S. D., et al. (2002) Pancreatic cancer. Curr. Probl. Cancer 26, 176–275.

    Article  PubMed  Google Scholar 

  2. Takaori, K., Hruban, R. H., Maitra, A., and Tanigawa, N. (2004) Pancreatic intraepithelial neoplasia. Pancreas 28, 257–262.

    Article  PubMed  Google Scholar 

  3. Kern, S. E., Hruban, R. H., Hidalgo, M., and Yeo, C. J. (2002) An introduction to pancreatic adenocarcinoma genetics, pathology and therapy. Cancer Biol. Ther. 1, 607–613.

    CAS  PubMed  Google Scholar 

  4. Louvet, C., Andre, T., Lledo, G., et al. (2002) Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. J. Clin. Oncol. 20, 1512–1518.

    Article  CAS  PubMed  Google Scholar 

  5. Hruban, R. H., Iacobuzio-Donahue, C., Wilentz, R. E., Goggins, M., and Kern, S. E. (2001) Molecular pathology of pancreatic cancer. Cancer J. 7, 251–258.

    CAS  PubMed  Google Scholar 

  6. Li, D., Xie, K., Wolff, R., and Abbruzzese, J. L. (2004) Pancreatic cancer. Lancet 363, 1049–1057.

    Article  CAS  PubMed  Google Scholar 

  7. Goggins, M., Hruban, R. H., and Kern, S. E. (2000) BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am. J. Pathol. 156, 1767–1771.

    Article  CAS  PubMed  Google Scholar 

  8. Day, J. D., Digiuseppe, J. A., Yeo, C., et al. (1996) Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum. Pathol. 27, 119–124.

    Article  CAS  PubMed  Google Scholar 

  9. Caldas, C., Hahn, S. A., da Costa, L. T., et al. (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet. 8, 27–32.

    Article  CAS  PubMed  Google Scholar 

  10. Hahn, S. A., Schutte, M., Hoque, A. T., et al. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350–353.

    Article  CAS  PubMed  Google Scholar 

  11. Schutte, M., Hruban, R. H., Geradts, J., et al. (1997) Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res. 57, 3126–3130.

    CAS  PubMed  Google Scholar 

  12. Berman, D. M., Karhadkar, S. S., Maitra, A., et al. (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425, 846–851.

    Article  CAS  PubMed  Google Scholar 

  13. Miyamoto, Y., Maitra, A., Ghosh, B., et al. (2003) Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3, 565–576.

    Article  CAS  PubMed  Google Scholar 

  14. Iacobuzio-Donahue, C. A., Maitra, A., Shen-Ong, G. L., et al. (2002) Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am. J. Pathol. 160, 1239–1249.

    Article  CAS  PubMed  Google Scholar 

  15. Iacobuzio-Donahue, C. A., Maitra, A., Olsen, M., et al. (2003) Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 162, 1151–1162.

    Article  CAS  PubMed  Google Scholar 

  16. Iacobuzio-Donahue, C. A., Ashfaq, R., Maitra, A., et al. (2003) Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res. 63, 8614–8622.

    CAS  PubMed  Google Scholar 

  17. Gronborg, M., Bunkenborg, J., Kristiansen, T. Z., et al. (2004) Comprehensive proteomic analysis of human pancreatic juice. J. Proteome Res. 3, 1042–1055.

    Article  CAS  PubMed  Google Scholar 

  18. Ryu, B., Jones, J., Blades, N. J., et al. (2002) Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res. 62, 819–826.

    CAS  PubMed  Google Scholar 

  19. Argani, P., Rosty, C., Reiter, R. E., et al. (2001) Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res. 61, 4320–4324.

    CAS  PubMed  Google Scholar 

  20. Argani, P., Iacobuzio-Donahue. C., Ryu. B., et al. (2001) Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin. Cancer Res. 7, 3862–3868.

    CAS  PubMed  Google Scholar 

  21. Rosty, C., Christa, L., Kuzdzal, S., et al. (2002) Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 62, 1868–1875.

    CAS  PubMed  Google Scholar 

  22. Koopmann, J., Fedarko, N. S., Jain, A., et al. (2004) Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 13, 487–491.

    CAS  PubMed  Google Scholar 

  23. Shalon, D., Smith, S. J., and Brown, P. O. (1996) A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 6, 639–645.

    Article  CAS  PubMed  Google Scholar 

  24. Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. (1995) Serial analysis of gene expression. Science 270, 484–487.

    Article  CAS  PubMed  Google Scholar 

  25. Pandey, A. and Mann, M. (2000) Proteomics to study genes and genomes. Nature 405, 837–846.

    Article  CAS  PubMed  Google Scholar 

  26. Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470.

    Article  CAS  PubMed  Google Scholar 

  27. DeRisi, J., Penland, L., Brown, P. O., et al. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14, 457–460.

    Article  CAS  PubMed  Google Scholar 

  28. Pollack, J. R. (2002) Comparative genomic hybridization using cDNA microarrays. In: DNA microarrays: A Molecular Cloning Manual, Sambrook, J., ed. Cold Spring Harbor Press, pp. 363–369.

    Google Scholar 

  29. Van Gelder, R. N., von Zastrow, M. E., Yool, A., Dement, W. C., Barchas, J. D., and Eberwine, J. H. (1990) Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. USA 87, 1663–1667.

    Article  PubMed  Google Scholar 

  30. Polyak, K. and Riggins, G. J. (2001) Gene discovery using the serial analysis of gene expression technique: implications for cancer research. J. Clin. Oncol. 19, 2948–2958.

    CAS  PubMed  Google Scholar 

  31. Kenzelmann, M. and Muhlemann, K. (1999) Substantially enhanced cloning efficiency of SAGE (serial analysis of gene expression) by adding a heating step to the original protocol. Nucleic Acids Res. 27, 917–918.

    Article  CAS  PubMed  Google Scholar 

  32. Angelastro, J. M., Klimaschewski, L. P., and Vitolo, O. V. (2000) Improved NlaIII digestion of PAGE-purified 102 bp ditags by addition of a single purification step in both the SAGE and microSAGE protocols. Nucleic Acids Res. 28, e62.

    Article  CAS  PubMed  Google Scholar 

  33. Datson, N. A., van der Perk-de Jong, J., van den Berg, M. P., de Kloet, E. R., and Vreugdenhil, E. (1999) MicroSAGE: a modified procedure for serial analysis of gene expression in limited amounts of tissue. Nucleic Acids Res. 27, 1300–1377.

    Article  CAS  PubMed  Google Scholar 

  34. Peters, D. G., Kassam, A. B., Yonas, H., O’Hare, E. H., Ferrell, R. E., and Brufsky, A. M. (1999) Comprehensive transcript analysis in small quantities of mRNA by SAGE-lite. Nucleic Acids Res. 27, e39.

    Article  CAS  PubMed  Google Scholar 

  35. Foss, C. A., Maitra, A., Iacobuzio-Donahue, C., Kern, S., snf Pomper, M. G. (2004) [125I]anti-Claudin 4 and [125I]anti-PSCA monoclonal antibodies as novel imaging agents for human pancreatic cancer in xenograft-bearing mice, In Proceedings of the Third Annual Meeting of the Society for Molecular Imaging, St. Louis, MO.

    Google Scholar 

  36. Hassan, R., Bera, T., and Pastan, I. (2004) Mesothelin: a new target for immunotherapy. Clin. Cancer Res. 10, 3937–3942.

    Article  CAS  PubMed  Google Scholar 

  37. Thomas, A. M., Santarsiero, L. M., Lutz, E. R., et al. (2004) Mesothelinspecific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients. J. Exp. Med. 200, 297–306.

    Article  CAS  PubMed  Google Scholar 

  38. Rosty, C. and Goggins, M. (2002) Early detection of pancreatic carcinoma. Hematol. Oncol. Clin. North Am. 16, 37–52.

    Article  PubMed  Google Scholar 

  39. Nichols, L. S., Ashfaq, R., and Iacobuzio-Donahue, C. A. (2004) Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am. J. Clin. Pathol. 121, 226–230.

    Article  CAS  PubMed  Google Scholar 

  40. Michl, P., Buchholz, M., Rolke, M., et al. (2001) Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121, 678–684.

    Article  CAS  PubMed  Google Scholar 

  41. Offner, S., Hekele, A., Teichmann, U., et al. (2005) Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy. Cancer Immunol. Immunother. 54, 431–445.

    Article  CAS  PubMed  Google Scholar 

  42. Tuteja, R. and Tuteja, N. (2004) Serial analysis of gene expression (SAGE): unraveling the bioinformatics tools. Bioessays 26, 916–922.

    Article  CAS  PubMed  Google Scholar 

  43. Lash, A. E., Tolstoshev, C. M.,Wagner, L., et al. (2000) SAGEmap: a public gene expression resource. Genome Res. 10, 1051–1060.

    Article  CAS  PubMed  Google Scholar 

  44. Lal, A., Lash, A. E., Altschul, S. F., et al. (1999) A public database for gene expression in human cancers. Cancer Res. 59, 5403–5407.

    CAS  PubMed  Google Scholar 

  45. Wolters, D. A., Washburn, M. P., and Yates, J. R., 3rd. (2001) An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73, 5683–5690.

    Article  CAS  PubMed  Google Scholar 

  46. Washburn, M. P., Wolters, D., and Yates, J. R., 3rd. (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242–247.

    Article  CAS  PubMed  Google Scholar 

  47. Switzer, R. C., 3rd, Merril, C. R., and Shifrin, S. (1979) A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal. Biochem. 98, 231–237.

    Article  CAS  PubMed  Google Scholar 

  48. Neuhoff, V., Arold, N., Taube, D., and Ehrhardt, W. (1988) Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9, 255–262.

    Article  CAS  PubMed  Google Scholar 

  49. Rabilloud, T., Carpentier, G., and Tarroux, P. (1988) Improvement and simplification of low-background silver staining of proteins by using sodium dithionite. Electrophoresis 9, 288–291.

    Article  CAS  PubMed  Google Scholar 

  50. Ishihama,Y., Rappsilber, J., Andersen, J. S., and Mann, M. (2002) Microcolumns with self-assembled particle frits for proteomics. J. Chromatogr. A 979, 233–239.

    Article  CAS  PubMed  Google Scholar 

  51. Pruitt, K. D., Tatusova, T., and Maglott, D. R. (2005) NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 33, D501–D504.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

A.M. is supported by an American Association for Cancer Research-PanCAN Career Development Award, the Lustgarten Foundation for Pancreatic Cancer Research, and National Cancer Institute R01CA113669.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc.

About this protocol

Cite this protocol

Beaty, R.M., Gronborg, M., Pollack, J.R., Maitra, A. (2007). Target Discovery and Validation in Pancreatic Cancer. In: Sioud, M. (eds) Target Discovery and Validation Reviews and Protocols. Methods in Molecular Biology™, vol 360. Humana Press. https://doi.org/10.1385/1-59745-165-7:57

Download citation

  • DOI: https://doi.org/10.1385/1-59745-165-7:57

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-656-6

  • Online ISBN: 978-1-59745-165-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics